Subtype
Bladder Neoplasm
CI-CAN-00001978Explore in graph →
Non-malignant390 active trials10 approved drugs25 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001978Explore in graph →
Clinical trials
1,701 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04566614 | Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsies(PREVAILctDNA) | completed | — | 128 | Royal Marsden NHS Foundation TrustOTHER | 1 | Apr 6, 2025 | clinicaltrials |
| NCT03469362 | Intracorporeal vs Extracorporeal Urinary Diversion After Robot Assisted Radical Cystectomy | completed | N/A | 38 | University of MiamiOTHER | 1 | Mar 25, 2025 |
| clinicaltrials |
| NCT06505746 | A Study of Real-world Treatment of Adults With Urothelial Cancer in South Korea and Saudi Arabia | completed | — | 287 | Astellas Pharma Singapore Pte. Ltd.INDUSTRY | 1 | Mar 24, 2025 | clinicaltrials |
| NCT02365766 | Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects | completed | Phase 1 / Phase 2 | 83 | Jason R. BrownOTHER | 1 | Mar 18, 2025 | clinicaltrials |
| NCT04995809 | Effect of Pelvic Radiotherapy on the Intestinal Microbiome and Metabolome(EPRIMM) | completed | — | 18 | The Christie NHS Foundation TrustOTHER | 1 | Mar 12, 2025 | clinicaltrials |
| NCT02662309 | Preoperative MPDL3280A in Transitional Cell Carcinoma of the Bladder(ABACUS) | completed | Phase 2 | 96 | Queen Mary University of LondonOTHER | 4 | Mar 10, 2025 | clinicaltrials |
| NCT05978570 | Physical Therapy in Pre-cystectomy Patients | completed | — | 68 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Mar 4, 2025 | clinicaltrials |
| NCT02567409 | Cisplatin and Gemcitabine Hydrochloride With or Without Berzosertib in Treating Patients With Metastatic Urothelial Cancer | completed | Phase 2 | 87 | National Cancer Institute (NCI)NIH | 1 | Mar 3, 2025 | clinicaltrials |
| NCT06851520 | Retrospective Analysis of Different Quadratus Lumborum Block Techniques on Recovery Quality and Analgesic Consumption in Radical Cystectomy Patients(QLB-CYS) | completed | — | 32 | Namik Kemal UniversityOTHER | 1 | Feb 28, 2025 | clinicaltrials |
| NCT00627432 | Gemcitabine With Or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Bladder Cancer | completed | Phase 2 | 44 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 18, 2025 | clinicaltrials |
| NCT00583349 | Intravesicular Abraxane for Treatment-Refractory Bladder Cancer | completed | Phase 1 / Phase 2 | 46 | Columbia UniversityOTHER | 1 | Feb 17, 2025 | clinicaltrials |
| NCT06818799 | Thulium Laser En-bloc Resection of Primary Non-muscle Invasive Bladder Cancer | completed | N/A | 50 | Helwan UniversityOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT01638533 | Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction | completed | Phase 1 | 37 | National Cancer Institute (NCI)NIH | 2 | Feb 7, 2025 | clinicaltrials |
| NCT01489813 | Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer Treatment | completed | Phase 2 | 36 | Emory UniversityOTHER | 1 | Feb 5, 2025 | clinicaltrials |
| NCT03404791 | A Study of TAR-200 in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder Who Are Ineligible for or Refuse Cisplatin-based Chemotherapy and Who Are Unfit for Radical Cystectomy | completed | Phase 1 | 35 | Janssen Research & Development, LLCINDUSTRY | 2 | Feb 4, 2025 | clinicaltrials |
| NCT04492007 | Feasibility Testing of Patient Reported Outcomes - Informed Symptom Management System (PRISMS)(PRISMS) | completed | N/A | 46 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Feb 3, 2025 | clinicaltrials |
| NCT01697306 | The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guerin on the Quality of Life in Superficial Bladder Cancer | completed | Phase 2 | 120 | A.O.U. Città della Salute e della ScienzaOTHER | 1 | Jan 30, 2025 | clinicaltrials |
| NCT03473730 | Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer | completed | Early Phase 1 | 17 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 30, 2025 | clinicaltrials |
| NCT04576286 | Holmium Versus Bipolar en Bloc Transurethral Resection of Urothelium Tumor of the Urinary Bladder | completed | Phase 2 | 100 | Ain Shams UniversityOTHER | 1 | Jan 28, 2025 | clinicaltrials |
| NCT06796413 | Loop Resection or Cold-cup Biopsy? A Study Comparing the Accuracy of Muscle Samples During Bladder Tumor Surgery | completed | N/A | 120 | University of StellenboschOTHER | 1 | Jan 28, 2025 | clinicaltrials |
| NCT02662062 | Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer(PCR-MIB) | completed | Phase 2 | 28 | Australian and New Zealand Urogenital and Prostate Cancer Trials GroupOTHER | 1 | Jan 27, 2025 | clinicaltrials |
| NCT03154190 | Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer | completed | N/A | 128 | Stanford UniversityOTHER | 1 | Jan 24, 2025 | clinicaltrials |
| NCT05742867 | A Study to Evaluate Treatment Preferences for Japanese Participants With Muscle-invasive Urothelial Carcinoma of the Bladder(SNUGGLE) | completed | — | 115 | Bristol-Myers SquibbINDUSTRY | 1 | Jan 23, 2025 | clinicaltrials |
| NCT06789224 | Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device(REMOVE) | completed | N/A | 136 | Lindis Bloodcare GmbHINDUSTRY | 1 | Jan 23, 2025 | clinicaltrials |
| NCT06768346 | Hyperthermic Intra-Vesical Chemotherapy(HIVECII) | completed | N/A | 259 | Queen Mary University of LondonOTHER | 1 | Jan 10, 2025 | clinicaltrials |
| NCT05578898 | CLEAR Care Companion Application | completed | N/A | 28 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jan 8, 2025 | clinicaltrials |
| NCT04314778 | FITBIT Study on Mobility and Readmissions After Radical Cystectomy(FITBIT) | completed | N/A | 64 | University of PennsylvaniaOTHER | 1 | Dec 24, 2024 | clinicaltrials |
| NCT04028479 | The Registry of Oncology Outcomes Associated With Testing and Treatment(ROOT) | completed | — | 167 | Taproot HealthINDUSTRY | 1 | Dec 18, 2024 | clinicaltrials |
| NCT05939856 | Lymph Node Dissection Before or After Cystectomy(LBOACP) | completed | N/A | 50 | Jagiellonian UniversityOTHER | 1 | Dec 10, 2024 | clinicaltrials |
| NCT04806178 | Immunological Response of Bladder Cancer Patients Under BCG(IMMUNOBCG) | completed | Phase 3 | 30 | University of Campinas, BrazilOTHER | 1 | Dec 9, 2024 | clinicaltrials |
| NCT01224665 | S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer | completed | N/A | 658 | SWOG Cancer Research NetworkNETWORK | 2 | Nov 29, 2024 | clinicaltrials |
| NCT03534804 | Cabozantinib Plus Pembrolizumab as First-Line Therapy for Cisplatin-Ineligible Advanced Urothelial Carcinoma(PemCab) | completed | Phase 2 | 37 | University of UtahOTHER | 1 | Nov 26, 2024 | clinicaltrials |
| NCT02462239 | Impact of Positron Emission Tomography (PET) Imaging in Muscle-invasive Urothelial Carcinoma of the Bladder Staging(PET MUSE) | completed | N/A | 292 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Nov 22, 2024 | clinicaltrials |
| NCT02619253 | Phase I/Ib Study of Pembrolizumab With Vorinostat for Patients With Advanced Renal or Urothelial Cell Carcinoma | completed | Phase 1 | 52 | Nabil AdraOTHER | 1 | Nov 18, 2024 | clinicaltrials |
| NCT06688643 | The Impact of Intrathecal Morphine Versus Continuous Epidural Analgesia on Return of Bowel Function in Patients Undergoing Laparoscopic Ileal Conduit | completed | N/A | 58 | Xiaguang DuanOTHER | 1 | Nov 14, 2024 | clinicaltrials |
| NCT04036877 | Mood Disorders Bladder Cancer | completed | — | 358 | University of Kansas Medical CenterOTHER | 1 | Nov 6, 2024 | clinicaltrials |
| NCT01627197 | Adjuvant Intraarterial Chemotherapy Following Surgery to Treat Locally Advanced Bladder Cancer | completed | Phase 3 | 186 | Sun Yat-sen UniversityOTHER | 1 | Nov 5, 2024 | clinicaltrials |
| NCT06657755 | Evaluation of ENPP1 Expression and Immune Response in Bladder Cancer Patients(ENPP1-BC) | completed | — | 12 | Lanzhou University Second HospitalOTHER | 1 | Oct 24, 2024 | clinicaltrials |
| NCT06632340 | Effect of Tumor Base Size in Bladder Cancer | completed | N/A | 130 | Ankara Training and Research HospitalOTHER | 1 | Oct 16, 2024 | clinicaltrials |
| NCT06337305 | Resiliency in Patients Undergoing Radical Cystectomy for Bladder Cancer | completed | — | 74 | University of Kansas Medical CenterOTHER | 1 | Oct 15, 2024 | clinicaltrials |
| NCT05905276 | Enhanced Recovery After Surgery (ERAS) for Ambulatory TURBT | completed | N/A | 100 | Johns Hopkins UniversityOTHER | 1 | Oct 4, 2024 | clinicaltrials |
| NCT05600322 | Comparative Study of Hexvix Blue Light Cystoscopy and White Light Cystoscopy in the Detection of Bladder Cancer | completed | Phase 3 | 158 | PhotocureINDUSTRY | 1 | Oct 3, 2024 | clinicaltrials |
| NCT04713891 | A Study of KF-0210 in Advanced Solid Tumors Patients | completed | Phase 1 | 14 | Keythera Pharmaceuticals (Australia) Pty LtdINDUSTRY | 1 | Sep 24, 2024 | clinicaltrials |
| NCT00981656 | Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer | completed | Phase 2 | 37 | Radiation Therapy Oncology GroupNETWORK | 1 | Sep 19, 2024 | clinicaltrials |
| NCT02177695 | S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer(COXEN) | completed | Phase 2 | 237 | SWOG Cancer Research NetworkNETWORK | 1 | Sep 19, 2024 | clinicaltrials |
| NCT03532451 | Phase Ib Feasibility Trial of Neoadjuvant Nivolumab/Lirilumab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer(PrE0807) | completed | Phase 1 | 43 | PrECOG, LLC.OTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT04593862 | Bladder Cancer and ExeRcise Training During IntraVesical ThErapy(BRAVE) | completed | Phase 2 | 25 | University of AlbertaOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT05136898 | Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC) | completed | Phase 3 | 8 | UroGen Pharma Ltd.INDUSTRY | 1 | Sep 19, 2024 | clinicaltrials |
| NCT05344950 | Connecting Audio and Radio Sensing Systems to Improve Care at Home(AURA) | completed | — | 13 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06395701 | Trimodality Treatment in Bladder Cancer | completed | — | 200 | Consorci Sanitari de TerrassaOTHER | 1 | Sep 19, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Apr 6, 2025source: clinicaltrials